IDX Share Price Performance
AU$0
-2.98 (-100.00%)
Price AU$0
Fair ValueAU$3.36
Share Pricen/a
Integral Diagnostics Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
IDX Community Narratives
AN
Fair Value AU$3.36 20.3% undervalued intrinsic discount
MRI Licensing And Lung Screening Will Expand Imaging Potential
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AN
Fair Value AU$4 33.0% undervalued intrinsic discount
AI And Teleradiology Expansion Will Drive Long Term Diagnostic Imaging Leadership
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value AU$2.49 7.7% overvalued intrinsic discount
MRI Deregulation And Teleradiology Expansion Will Shape Modest Future Earnings Improvements
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
MRI Deregulation And Teleradiology Expansion Will Shape Modest Future Earnings Improvements
Catalysts About Integral Diagnostics Integral Diagnostics operates radiology clinics across Australia and New Zealand, providing specialist diagnostic imaging services supported by teleradiology and AI enabled workflows. What are the underlying business or industry changes driving this perspective?Read more
11
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AU$2.49
7.7% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
13.8% p.a.
Profit Margin
7.07%
Future PE
17.29x
Price in 2029
AU$3.03
AI And Teleradiology Expansion Will Drive Long Term Diagnostic Imaging Leadership
Catalysts About Integral Diagnostics Integral Diagnostics is a specialist provider of diagnostic imaging services across Australia and New Zealand, with a growing focus on higher value modalities and teleradiology. What are the underlying business or industry changes driving this perspective?Read more
35
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AU$4
33.0% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
15.64% p.a.
Profit Margin
8.9%
Future PE
21.06x
Price in 2028
AU$4.86
MRI Licensing And Lung Screening Will Expand Imaging Potential
Key Takeaways Increased MRI capacity, strong merger integration, and new screening programs are driving sustained revenue growth and expanding margins for the core imaging business. Scaling teleradiology, use of AI, and easing labor constraints position the company to mitigate clinician shortages and boost future profitability.Read more
80
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AN
AU$3.36
20.3% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
12.85% p.a.
Profit Margin
7.55%
Future PE
22.31x
Price in 2028
AU$4.06
Trending Discussion
Recently Updated Narratives
AN
MRI Deregulation And Teleradiology Expansion Will Shape Modest Future Earnings Improvements
Fair Value: AU$2.49 7.7% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AI And Teleradiology Expansion Will Drive Long Term Diagnostic Imaging Leadership
Fair Value: AU$4 33.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
MRI Licensing And Lung Screening Will Expand Imaging Potential
Fair Value: AU$3.36 20.3% undervalued intrinsic discount
11 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Integral Diagnostics Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 23, 2026
- 0.013
- 31.25%
- 0.75%
- 49.2%
About IDX
- Founded
- 1967
- Employees
- 3025
- CEO
- WebsiteView website
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.
